FDA Inspection 1148403 — Hisun Pharmaceutical Hangzhou Co., Ltd

Hisun Pharmaceutical Hangzhou Co., Ltd — FEI 3008481334

The FDA completed an inspection of Hisun Pharmaceutical Hangzhou Co., Ltd on July 20, 2021 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 20, 2021
Fiscal Year
2021
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Hangzhou (China)